Uncategorized

PHARMA/POLICY: Medicare Part D

This is a complete cop-out as I’m still hacking away on my Hillarycare piece, and haven’t even read this, but the article in Health Affairs called Riding The Rollercoaster: The Ups And Downs In Out-Of-Pocket Spending Under The Standard Medicare Drug Benefit looks pretty interesting and I think suggests that we have an ongoing spending problem emerging in Part D even before it hits!.

Does one of my contributors care to read it and review? (email me for a Health Affairs pw if you haven’t got one)

Livongo’s Post Ad Banner 728*90

3
Leave a Reply

3 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
2 Comment authors
Gregory D. PawelskiAbby Recent comment authors
newest oldest most voted
Gregory D. Pawelski
Guest
Gregory D. Pawelski

Report: Doctors’ $275M Study Questioned
By KEVIN FREKING
The Associated Press
Tuesday, August 29, 2006
http://www.boston.com/yourlife/health/aging/articles/2006/08/29/report_doctors_275m_study_questioned/
Medicare Drug Plan Helps Patients Fight Cancer
By Steven Reinberg
HealthDay Reporter
http://news.yahoo.com/s/hsn/20060912/hl_hsn/medicaredrugplanhelpspatientsfightcancer&printer=1

Gregory D. Pawelski
Guest
Gregory D. Pawelski

I know that the “doughnut hole” and the “drug price negotiation” needs to be drastically changed before 2006. My specific interest in the new Medicare bill has been in the “drug concession” provision. What that did was to remove the profit incentive from the choice of cancer treatments, which were financial incentives for infusional-therapy over oral-therapy or non-chemotherapy, and financial incentives for choosing some drugs over others. Patients should receive what is best for them and not what is best for their oncologists. The new Medicare bill offers patients benefits they did not have before, some coverage for oral-chemotherapy drugs… Read more »

Abby
Guest
Abby

I don’t think I have the expertise to do a review, but I’ve got a shameless request. When you get around to writing about the failure of HillaryCare, could you please address Brad DeLong’s criticisms of her managerial style?
DeLong said that she needlessly antagonized people on the Hill and that she ignored substantive criticisms of her plan. You can read his comments in a post explaining why she should never be president.